BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Sep 15, 2025; 16(9): 107517
Published online Sep 15, 2025. doi: 10.4239/wjd.v16.i9.107517
Type 2 diabetes mellitus: Isn’t it time to update the terminology?
Arkiath Veettil Raveendran
Arkiath Veettil Raveendran, Department of Internal Medicine, Government Medical College, Kozhikode 673010, Kerala, India
Author contributions: Raveendran AV designed the manuscript, collected the data, wrote and revised the manuscript. The author read and approved the final version of the manuscript to be published.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Arkiath Veettil Raveendran, MD, FRCP, Chief Physician, Department of Internal Medicine, Government Medical College, Mavoor Road, Kozhikode 673010, Kerala, India. raveendranav@yahoo.co.in
Received: March 25, 2025
Revised: May 20, 2025
Accepted: August 19, 2025
Published online: September 15, 2025
Processing time: 170 Days and 11.3 Hours
Abstract

There is a paradigm shift in the approach to the treatment of type 2 diabetes mellitus (T2DM) based on recent research. “Twin cycle hypothesis” and remission of diabetes proved that diabetes is a disease due to excess fat accumulation above the personal fat threshold. Hence, weight reduction and, whenever possible, achievement of remission has become therapeutic target for the management of T2DM. Increasing evidence suggests that T2DM is a part of the spectrum of diseases caused by excess fat accumulation. Hence, it indeed is the need of the hour to update the terminologies to indicate that T2DM is part of the disease spectrum of excess fat accumulation to improve awareness among healthcare professionals and the public to achieve overall holistic management of the disease spectrum. In this short article, we analyze these factors and propose a new terminology for adaptation worldwide.

Keywords: Diabetes mellitus; Adiposity; Obesity; Personal fat threshold; Personal organ-specific fat threshold; Adiposity induced metabolic dysfunction associated diseases; Metabolic dysfunction associated hyperglycemic disease

Core Tip: Recent research has led to a paradigm shift in the treatment approach for type 2 diabetes mellitus (T2DM). The “twin cycle hypothesis” and evidence supporting diabetes remission have shown that the condition results from excess fat accumulation above the personal fat threshold. When excess fat deposition leads to organ dysfunction, we term it as adiposity-induced metabolic dysfunction associated disease. T2DM is a part of the spectrum of diseases caused by excess fat accumulation. Hence, it is the need of the hour to update the terminology and we propose a new terminology for T2DM. The proposed terminology is more reflective of the multifaceted nature of the disease, reshapes the management protocols and helps in earlier diagnosis and treatment.